GR148672X
GR148672X is a triacyglycerol hydrolase (TGH) inhibitor with an IC50 of 4 nM extracted from patent WO 2001016358 A2.
Product Specifications
CAS Number
[263890-70-6]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Others
Type
Reference compound
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/GR148672X.html
Purity
99.58
Solubility
DMSO : 41.67 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=CS1)/C(C(C(F)(F)F)=O)=N\NC2=CC=CC(C)=C2
Molecular Formula
C15H11F3N2O2S
Molecular Weight
340.32
Precautions
H302, H315, H319, H335
References & Citations
[1]Catherine Sylvia Borg-Capra, et al. Method of screening for triacyglycerol hydrolase inhibitors . WO 2001016358 A2.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
169990-01 250 µg
Heptelidic Acid (Koningic acid, Avocettin, FO-4443, BRN 5091359) discontinued
Ask
View Details 169990-02 1 mg
Heptelidic Acid (Koningic acid, Avocettin, FO-4443, BRN 5091359) discontinued
Ask
View Details 
MBS6373247-01 0.1 mL
CD7 (T-cell Antigen CD7, GP40, T-cell Leukemia Antigen, T-cell Surface Antigen Leu-9, TP41) APC
Ask
View Details